InsiderTrades

Form 4 for VRCA Verrica Pharmaceuticals Inc.

Accepted 2024-09-23 00:00:00 ET · period of report 2024-09-19 · accession 0001415889-24-023835 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
MI 2024-09-23 2024-09-19 VRCA Manning Paul B Dir, 10% G - Gift $0.00 +0.00 0 New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-09-19 G A 891,870.42 $0.00 891,870.42 I By trust — — (F2) These shares are held in separate trusts for the benefit of the Reporting Person's immediate family members. The Reporting Person's spouse is trustee of each trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
2 Common Common Stock 2024-09-19 G A 891,870.42 $0.00 891,870.42 I By trust — — (F2) These shares are held in separate trusts for the benefit of the Reporting Person's immediate family members. The Reporting Person's spouse is trustee of each trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
3 Common Common Stock 2024-09-19 G A 891,870.41 $0.00 891,870.41 I By trust — — (F2) These shares are held in separate trusts for the benefit of the Reporting Person's immediate family members. The Reporting Person's spouse is trustee of each trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
4 Common Common Stock 2024-09-19 G D 2,675,611.25 $0.00 0 I By GRAT — —